Caspolyn 50 & 70 50 mg, 70 mg Powder for concentrate for solution for infusion
PDF Leaflet Revision Date: 04 June 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Empirical therapy for presumed fungal infections and treatment of invasive candidiasis.
Dosage (summary)
70 mg loading dose on Day 1, then 50 mg daily; adjust based on clinical response.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; avoid breastfeeding.
Key Drug Interactions
- Ciclosporin
- Rifampicin
- Dexamethasone
Contraindications
- Hypersensitivity to caspofungin
- Severe hepatic insufficiency
Common side effects
- Hypersensitivity reactions
- Headache
- Nausea
- Diarrhoea
Counselling Points
- Monitor for allergic reactions
- Avoid driving if dizzy
- Report any unusual symptoms
Serious warnings
- Anaphylaxis
- Hepatic dysfunction
- Stevens-Johnson Syndrome
Important Disclaimer
The Caspolyn 50 & 70 50 mg, 70 mg Powder for concentrate for solution for infusion professional information leaflet below is the property of Accord Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
